2019-2023 U.S. POC/Point-of-Care Clinical Chemistry Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends--Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

This new 373-page report from 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for clinical chemistry procedures
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major clinical chemistry reagent and instrument suppliers.

Current and Emerging Products

- Analysis of clinical chemistry procedures performed in POC testing locations.
- Review of leading clinical chemistry analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing clinical Chemistry
   testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new clinical chemistry instruments and reagent systems
   with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and 's proprietary data files.

Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Review of Clinical Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cholesterol
12. Cholinesterase
13. Creatinine
14. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium

15. Ferritin
16. Follate/Folic Acid
17. Fructosamine
18. Gamma-Glutamyl Transpeptidase (GGT)
19. Glucose
20. High Density Lipoprotein (HDL)
21. Iron
22. Lactate Dehydrogenase (LDH)
23. Magnesium
24. Phosphorus
25. Protein
26. Triglycerides
27. Troponin
28. Uric Acid
29. Urinalysis
30. Vitamin B12
Instrumentation: Chemistry Analyzers Manufactured by:
- Abaxis
- Abbott
- Alfa Wassermann
- Awareness Technologies
- Beckman Coulter/Danaher
- bioMeriuex
- Carolina Chemistries
- Horiba
- Inverness
- Medica
- Nova Biomedical
- Ortho-Clinical Diagnostics
- Polimedco
- Randox
- Roche
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)

? Overview
? ELISA
? Dot Immunobinding Assays
? Capillary Immunoassays
? Particle-Membrane Capture Immunoassay
? Enzyme Amplification
c. Fluorescent Immunoassays
? Fluorescent Polarization
? Time-Resolved Pulse Fluorescence
d. Luminescence
? Chemiluminescence
? Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
? Polymerase Chain Reaction
? Ligase Chain Reaction
? Branched DNA
? Q-Beta Replicase
? Strand Displacement Activation
? Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
? PPO
? HMO
f. Hospitals
g. Admissions
h. Length of Stay

i. Industry Diversification
j. Physician Demographics
k. Aging Population
? More Chronic Illness
? Disease Incidence
? Susceptibility to latrogenesis
? Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
E. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
F. Surgery Centers
1. Introduction
2. Market Summary

3. Market Structure
4. Test Volume and Sales Forecasts
G. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Birth Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. Major Suppliers Sales and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations

E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
- Abbott Laboratories
- AdnaGen/Alere
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE

List Of Tables

Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests
Major Companies Developing or Marketing
Ferritin Tests

Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests

U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., Office-Based Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry Test Volume
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry
Reagent Market Forecast By Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine
And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments
Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments
Routine and Special Chemistry Reagent
Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Reagent
Market Forecast by Test

U.S.A., Hospital ICUs/CCUs Routine
And Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine
And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine
And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry
Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes
Estimated Number of Facilities,
Beds and Occupancy Rate
U.S.A., Nursing Homes Routine
And Special Chemistry Test Volume Forecast

U.S.A., Nursing Homes Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles,
Panels and Individual Tests
U.S.A., Birth Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry
Diagnostic Products Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Analyzers, Estimated Market Shares
U.S.A., Major Suppliers of Immunodiagnostic
Products, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay
Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay
Analyzers, Estimated Market Shares

2019-2023 US Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.The new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the

USD 9800 View Report

2019-2023 UK Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies

Complete report $6,800.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.(No Suggestions) new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during

USD 6800 View Report

2019-2023 U.S. Microbiology Automated Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology and Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

Complete report $9,850.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.LeadingMarketResearch.coms new report is an analysis of major business opportunities emerging in the U.S. automated microbiology market during the next

USD 9850 View Report

2019-2023 U.S. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Forecasts

Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500. This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and

USD 2300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available